Drug Discovery · San Mateo, CA · Founded 2014 · Privately Held (backing)
Operator of a small molecule drug discovery firm intended to introduce new treatments for cancer patients. Vivace Therapeutics is based in San Mateo, CA and was founded in 2014. It was valued at $125 million at its later-stage round in Feb 2025, the last priced event on record. It has raised $105 million across 4 recorded rounds; the latest was a $35 million Series D in Feb 2025.
PMV mark · valuation
$125.0M
Oct 2026
Priced at
its later-stage round
Feb 2025
Total raised
$105.0M
Last round
Later Stage VC (Series D)
Feb 2025
Cap table — not yet on record
Vivace Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vivace Therapeutics with a free account
·The complete investor list: 11 names
·Watch Vivace Therapeutics: the Monday email on marks, rounds and moves
Where does Vivace Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Vivace Therapeutics's 4 recorded funding rounds.
